Domínguez CLG, Sánchez LF, Armenta FR

Language: Spanish
References: 16
Page: 380-384
PDF size: 223.57 Kb.

ABSTRACT

Introduction: The 22q11.2 deletion syndrome is a chromosomal anomaly that causes a clinical picture characterized by congenital malformations that include cardiac and endocrine defects, associated with abnormalities of the palate, facial dysmorphism and immunodeficiency. Case report: A 40-year-old female with congenital aortic stenosis, who presents frequent pharyngeal infections, in which the diagnoses of hypoparathyroidism, subclinical hypothyroidism associated with mild craniofacial anomalies were established, corresponding to 22q11.2 deletion syndrome that was confirmed. Her main problem to solve is the severe aortic stenosis despite being asymptomatic from the cardiovascular point of view.

REFERENCES

1. DiGeorge AM. Congenital absence of the thymus and its immunologic consequences: concurrence with congenital hypoparathyroidism. White Plains, NY: March of Dimes-Birth Defects Foundation; 1968. pp. 116-121.

2. Grati FR, Molina-Gomes D, Ferreira JC, Dupont C, Alesi V, Gouas L et al. Prevalence of recurrent pathogenic microdeletions and microduplications in over 9500 pregnancies. Prenat Diagn. 2015; 35 (8): 801-809.

3. Gamazon ER, Stranger BE. The impact of human copy number variation on gene expression. Brief Funct Genomics. 2015; 14 (5): 352-357.

4. Oskarsdóttir S, Vujic M, Fasth A. Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden. Arch Dis Child. 2004; 89 (2): 148-151.

5. Swillen A, McDonald-McGinn D. Developmental trajectories in 22q11.2 deletion. Am J Med Genet C Semin Med Genet. 2015; 169 (2): 172-181.

6. Bittel DC, Yu S, Newkirk H, Kibiryeva N, Holt A 3rd, Butler MG et al. Refining the 22q11.2 deletion breakpoints in DiGeorge syndrome by aCGH. Cytogenet Genome Res. 2009; 124 (2): 113-120.

7. Bassett AS, Chow EW, Husted J, Weksberg R, Caluseriu O, Webb GD et al. Clinical features of 78 adults with 22q11 Deletion Syndrome. Am J Med Genet A. 2005; 138 (4): 307-313.

8. Bravo SM. Caracterización fenotípica de una muestra clínica de pacientes con síndrome de deleción 22q11 [Tesis Doctoral]. Universidad Complutense de Madrid; 2017. pp. 50-65.

9. Thompson CA, Karelis J, Middleton FA, Gentile K, Coman IL, Radoeva PD et al. Associations between neurodevelopmental genes, neuroanatomy, and ultra high risk symptoms of psychosis in 22q11.2 deletion syndrome. Am J Med Genet B Neuropsychiatr Genet. 2017; 174 (3): 295-2314.

10. Vorstman JA, Breetvelt EJ, Duijff SN, Eliez S, Schneider M, Jalbrzikowski M et al. Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome. JAMA Psychiatry. 2015; 72 (4): 377-385.

11. Hook EB, Cross PK, Schreinemachers DM. Chromosomal abnormality rates at amniocentesis and in live-born infants. JAMA. 1983; 249 (15): 2034-2038.

12. Alva EC. Evolución y resultados en el tratamiento de las cardiopatías congénitas a nivel mundial. Acta Med. 2018; 16 (2): 105-107.

13. Alva EC, Gómez DF, Yañez GL. Estenosis valvular aórtica congénita. Actualización del tratamiento. Arch Cardiol Mex. 2006; 76 (S4): 152-157.

14. Otto CM, Prendergast B. Aortic-valve stenosis--from patients at risk to severe valve obstruction. N Engl J Med. 2014; 371 (8): 744-756.

15. Girdauskas E, Borger MA. Bicuspid aortic valve and associated aortopathy: an update. Semin Thorac Cardiovasc Surg. 2013; 25 (4): 310-316.

16. Verma S, Yanagawa B, Kalra S, Ruel M, Peterson MD, Yamashita MH et al. Knowledge, attitudes, and practice patterns in surgical management of bicuspid aortopathy: a survey of 100 cardiac surgeons. J Thorac Cardiovasc Surg. 2013; 146 (5): 1033-1040.e4.